A revolutionary blood test that can detect 12 common cancers before symptoms appear is now being trialled on 8,000 NHS patients. The test, developed in Britain, uses artificial intelligence to identify cancer with high accuracy. The miONCO-Dx test, created by UK biotech company Xgenera working with the University of Southampton, analyses microRNA in blood samples. These small molecules help regulate gene expression, and their abnormal levels can signal cancer’s presence. Health Secretary Wes Streeting announced £2.4 million in government funding to advance the technology. He spoke about his personal experience with cancer and emphasized that early detection is crucial for … Continue reading NHS Trials AI Blood Test Targeting Earlier Detection of 12 Cancers After High Accuracy Shown